Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 7/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | ACE | P12821 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2330374 | 1.00 | CTRB1 (0.51) | CTRB1CA2CA1ACEPTPN1 | |
| SCHEMBL2330376 | 1.00 | CTRB1 (0.51) | CTRB1CA2CA1ACEPTPN1 | |
| SCHEMBL989156 | 0.86 | CA2 (0.65) | CTRB1CA2CA1ACEPTPN1 | |
| SCHEMBL989155 | 0.86 | CA2 (0.65) | CTRB1CA2CA1ACEPTPN1 | |
| SCHEMBL3447634 | 0.86 | CA2 (0.65) | CTRB1CA2CA1ACEPTPN1 | |
| SCHEMBL5867358 | 0.85 | CA2 (0.50) | CA2CA1HPGD | |
| SCHEMBL9829492 | 0.84 | SLC1A2 (0.53) | CA2CA1ACEPTPN1C3AR1 | |
| SCHEMBL9829488 | 0.84 | SLC1A2 (0.53) | CA2CA1ACEPTPN1C3AR1 | |
| SCHEMBL25423794 | 0.83 | NPC1 (0.47) | CTRB1CA1IDO1HDAC3HDAC4 | |
| SCHEMBL698067 | 0.83 | CA2 (0.67) | CA2CA1HPGDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114749162-B | Functionalized chromatographic medium containing polymer nanofibers and preparation method thereof | 思拓凡生物工艺研发有限公司 | 2025-04-08 | — | — | CN | claimed |
| WO-2025062126-A1 | ELECTROSPUN COMPOSITE FIBERS AND USES THEREOF | ASTREA UK SERVICES LIMITED (GB) | 2025-03-27 | — | — | WO | claimed |
| CN-119390780-A | Method for purifying norvancomycin by using multi-mode filler | 神威药业（张家口）有限公司 | 2025-02-07 | — | — | CN | claimed |
| EP-3439780-B1 | CHROMATOGRAPHY MATRIX | CYTIVA BIOPROCESS R & D AB (SE) | 2024-07-03 | — | — | EP | claimed |
| US-11998890-B2 | Functionalised chromatography medium comprising polymer nanofibres and process of preparation thereof | PURIDIFY LTD. (GB) | 2024-06-04 | — | — | US | claimed |
| CN-114749162-A | Functionalized chromatography media comprising polymeric nanofibers and methods of making the same | 纯化迪发有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-108883394-B | Chromatography matrix | 思拓凡生物工艺研发有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-109414680-B | Functionalized chromatography media comprising polymeric nanofibers and methods of making the same | 纯化迪发有限公司 | 2022-04-19 | — | — | CN | claimed |
| US-20210346866-A1 | Functionalised Chromatography Medium Comprising Polymer Nanofibres and Process of Preparation Thereof | CYTIVA BIOPROCESS R&D AB (SE) | 2021-11-11 | — | — | US | claimed |
| EP-3834926-A1 | FUNCTIONALIZED CHROMATOGRAPHY MEDIA | PURIDIFY LTD. (GB) | 2021-06-16 | — | — | EP | claimed |
| EP-3129065-A1 | TARGETED DRUG DELIVERY THROUGH AFFINITY BASED LINKERS | Invictus Oncology Pvt. Ltd. (IN) | 2017-02-15 | — | — | EP | claimed |
| US-20170014528-A1 | TARGETED DRUG DELIVERY THROUGH AFFINITY BASED LINKERS | INVICTUS ONCOLOGY PVT. LTD. (IN) | 2017-01-19 | — | — | US | claimed |
| US-20160288089-A1 | CHROMATOGRAPHY MEDIUM | CYTIVA BIOPROCESS R&D AB (SE) | 2016-10-06 | — | — | US | claimed |
| WO-2016154574-A1 | RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME | BENEMILK OY (FI) | 2016-09-29 | — | — | WO | claimed |
| EP-3055059-A1 | CHROMATOGRAPHY MEDIUM | PURIDIFY LTD. (GB) | 2016-08-17 | — | — | EP | claimed |
| EP-2681528-B1 | SAMPLE PRESERVATION METHOD AND SAMPLE APPLICATION SUBSTRATE | GE HEALTHCARE UK LTD (GB) | 2016-08-17 | — | — | EP | claimed |
| WO-2015148126-A1 | TARGETED DRUG DELIVERY THROUGH AFFINITY BASED LINKERS | INVICTUS ONCOLOGY PVT. LTD. (IN) | 2015-10-01 | — | — | WO | claimed |
| WO-2015052465-A1 | CHROMATOGRAPHY MEDIUM | UCL BUSINESS PLC (GB) | 2015-04-16 | — | — | WO | claimed |
| US-20130330751-A1 | SAMPLE PRESERVATION METHOD AND SAMPLE APPLICATION SUBSTRATE | GE HEALTHCARE UK LIMITED (GB) | 2013-12-12 | — | — | US | claimed |
| WO-2012118428-A1 | SAMPLE PRESERVATION METHOD AND SAMPLE APPLICATION SUBSTRATE | GE HEALTHCARE UK LIMITED (GB) | 2012-09-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170014528-A1 | TARGETED DRUG DELIVERY THROUGH AFFINITY BASED LINKERS | ABCG2, ADAM8, TIE1 | CTRB1 3701/4885CA2 4109/4885CA1 3659/4885 |
| US-20210346866-A1 | Functionalised Chromatography Medium Comprising Polymer Nanofibres and Process of Preparation Thereof | NEFM, SGMS1, FIBP | CTRB1 4652/4885CA2 4795/4885CA1 4586/4885 |
| US-11998890-B2 | Functionalised chromatography medium comprising polymer nanofibres and process of preparation thereof | NEFM, SGMS1, FIBP | CTRB1 4652/4885CA2 4795/4885CA1 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.